Literature DB >> 9597855

Outcome after external decompression for massive cerebral infarction.

K Sakai1, K Iwahashi, K Terada, Y Gohda, M Sakurai, Y Matsumoto.   

Abstract

Acute ischemic stroke involving the entire vascular distribution of a carotid or middle cerebral artery can cause massive cerebral edema. This study evaluated external decompression for the treatment of massive stroke and analyzed possible prognostic factors. Twenty-four patients with acute massive cerebral infarction, which had progressed to tentorial herniation and impending death, underwent external decompression after medical therapy failed to achieve an effective response. The neurological outcome 2 months after surgery using the Glasgow Outcome Scale was severe disability in 14 patients, vegetative state in two, and death in eight. The overall mortality was 33%. Various characteristics (age, sex, etiology, side of hemispheric infarction, pupillary asymmetry, Japan Coma Scale, distribution of infarction, hemorrhagic infarction, midline shift, tentorial herniation) were evaluated to determine the factors associated with high mortality after surgical intervention. There was no statistically significant relationship between any variable and mortality. Mortality was especially high in the patients with preoperative consciousness level of 200, anterior, middle, and posterior cerebral artery territory infarction, and stage III of tentorial herniation. Postoperatively, all patients with severe disability returned to a clear level of consciousness. Six patients with dominant hemisphere stroke had some measure of communicative skills in spite of aphasia. External decompression is a life-saving treatment for patients with massive cerebral infarction and can provide a reasonable quality of life even for those with dominant hemisphere strokes. Decompressive surgery should be considered and performed as soon as possible if computed tomography demonstrates signs of descending tentorial herniation.

Entities:  

Mesh:

Year:  1998        PMID: 9597855     DOI: 10.2176/nmc.38.131

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  6 in total

1.  Long-term outcome and quality of life after craniectomy in speech-dominant swollen middle cerebral artery infarction.

Authors:  Jarle Sundseth; Antje Sundseth; Bente Thommessen; Lars G Johnsen; Marianne Altmann; Wilhelm Sorteberg; Karl-Fredrik Lindegaard; Jon Berg-Johnsen
Journal:  Neurocrit Care       Date:  2015-02       Impact factor: 3.210

2.  Outcome after decompressive craniectomy in patients with dominant middle cerebral artery infarction: A preliminary report.

Authors:  Amandeep Kumar; Manish Singh Sharma; Bhawani Shanker Sharma; Rohit Bhatia; Manmohan Singh; Ajay Garg; Rajinder Kumar; Ashish Suri; Poodipedi Sarat Chandra; Shashank Sharad Kale; Ashok Kumar Mahapatra
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

3.  Association of Japan Coma Scale score on hospital arrival with in-hospital mortality among trauma patients.

Authors:  Tetsuya Yumoto; Hiromichi Naito; Takashi Yorifuji; Toshiyuki Aokage; Noritomo Fujisaki; Atsunori Nakao
Journal:  BMC Emerg Med       Date:  2019-11-06

4.  Clinical Evaluation of Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction using 3D Area and Volume Calculations.

Authors:  Serkan Kitiş; Serdar Çevik; Kevser B Köse; Arzu Baygül; Serhat Cömert; Ülkün Ü Ünsal; Meliha G Papaker
Journal:  Ann Indian Acad Neurol       Date:  2020-12-01       Impact factor: 1.383

5.  Outcome following decompressive craniectomy for malignant middle cerebral artery infarction in patients older than 70 years old.

Authors:  Jae Won Yu; Jae-Hyung Choi; Dae-Hyun Kim; Jae-Kwan Cha; Jae-Taeck Huh
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-06-30

Review 6.  Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke.

Authors:  Eric Jüttler; Peter D Schellinger; Alfred Aschoff; Klaus Zweckberger; Andreas Unterberg; Werner Hacke
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.